Daewoong Co., Ltd
Reporting owner on Forms 3, 4 and 5, CIK 1985493.
- In the filer group Daewoong Co., Ltd
Daewoong Co., Ltd reported on 1 issuer in 2 filings, the latest a 13D/A filed 2026-11-10.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AEON · AEON Biopharma, Inc.CIK 1837607 | 10% owner | 1 | 2026-11-10 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AEON · AEON Biopharma, Inc.Class A Common Stock, $0.0001 par value… | 2026-10-30 | X exercised | +11,236,631 | $0.0001 | 23,188,345 | Form 4 |
| AEON · AEON Biopharma, Inc.Class A Common Stock, $0.0001 par value… | 2026-10-30 | J other | -3,822 | $0.294 | 23,184,523 | Form 4 |
| AEON · AEON Biopharma, Inc.Class A Common Stock, $0.0001 par value…, holding | 58,023 | Form 4 | ||||
| AEON · AEON Biopharma, Inc.Pre-Funded Warrant (right to buy), derivative | 2026-10-30 | X exercised | -11,236,631 | $0 | 0 | Form 4 |
| AEON · AEON Biopharma, Inc.Common Stock Warrant (right to buy), derivative, holding | 8,000,000 | Form 4 | ||||
| AEON · AEON Biopharma, Inc.Senior Secured Convertible Note, derivative, holding | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13D/A 0001213900-26-117881 | AEON | 2026-11-10 | ||
| Form 4 0001213900-26-117865 | AEON Biopharma, Inc. | 2026-11-10 |